Cumulative Incidence of Colorectal and Extracolonic Cancers in MLH1 and MSH2 Mutation Carriers of Hereditary Nonpolyposis Colorectal Cancer

Journal of Gastrointestinal Surgery

Volumn 2, Issue 1, 1998, Pages 67-71

  Lin, Kevin M ^a   Shashidharan, M ^a   Thorson, Alan G ^a,b   Ternent, Charles A ^a   Blatchford, Garnet J ^a   Christensen, Mark A ^a   Watson, Patrice ^a   Lemon, Stephen J ^a   Franklin, Barbara ^a   Karr, Beth ^a   Lynch, Jane ^a   Lynch, Henry T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARRIER PROTEIN; DNA BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MSH2; TUMOR PROTEIN;

ADULT; AGE; ARTICLE; BILIARY TRACT TUMOR; COLON TUMOR; COLORECTAL TUMOR; COMPARATIVE STUDY; DNA REPAIR; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HEALTH SURVEY; HETEROZYGOTE; HUMAN; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; MUTATION; OVARY TUMOR; PHENOTYPE; RECTUM TUMOR; RISK FACTOR; SEX DIFFERENCE; STOMACH TUMOR; URINARY TRACT CANCER;

ADENOSINE TRIPHOSPHATASES; ADULT; AGE FACTORS; BILIARY TRACT NEOPLASMS; CARRIER PROTEINS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PHENOTYPE; POPULATION SURVEILLANCE; PROTO-ONCOGENE PROTEINS; RECTAL NEOPLASMS; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 0032216468     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(98)80105-4     Document Type: Article

References (31)

1. Winawer SJ, Fletcher RH, Miller R, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
2. Bellacosa A, Genuardi M, Anti M, Viel A, Ponz de Leon M. Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 1996;62:353-364.
3. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114-1125.
4. Mecklin JP, Jarvinen HJ, Hakkiluoto A, et al. Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in Finland. Dis Colon Rectum 1995;38:588-593.
5. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78: 1149-1167.
6. Tomoda H, Baba H, Oshiro T. Clinical manifestations in patients with hereditary nonpolyposis colorectal cancer. J Surg Oncol 1996;61:262-266.
7. D'Emilia JC, Rodriguez-Bigas MA, Petrelli NJ. The clinical and genetic manifestations of hereditary nonpolyposis colorectal carcinoma. Am J Surg 1995;169:368-372.
8. Percesepe A, Anti M, Marra G, et al. Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer (HNPCC): Results of a multivariate analysis. Int J Cancer 1994;58:799-802.
9. Lynch HT, Smyrk TC, Cavalieri J, Lynch JF. Identification of an HNPCC family. Am J Gastroenterol 1994;89:605-609.
10. Whitehouse A, Taylor GR, Deeble J, et al. A carboxy terminal domain of the hMSH-2 gene product is sufficient for binding specific mismatched oligonucleotides. Biochem Biophys Res Commun 1996;225:289-295.
11. Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 1996;272:557-560.
12. Brown ML, Kessler LG. Use of gene tests to detect hereditary predisposition to cancer: What do we know about cost effectiveness? Int J Cancer 1996;69:55-57.
13. Papadopoulos N, Leach FS, Kinzler KW, Vogelstein B. Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nat Genet 1995;11:99-102.
14. Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995;56:1060-1066.
15. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 1994;24:516-526.
16. Horii A, Han HJ, Sasaki S, Shimada M, Nakamura Y. Cloning, characterization and chromosomal assignment of the human genes homologous to yeast PMS1, a member of mismatch repair genes. Biochem Biophys Res Commun 1994; 204:1257-1264.
17. Nystrom-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 1994;55:659-665.
18. Liu B, Parsons RE, Hamilton SR, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590-4459.
19. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer [see comments]. Science 1994;263:1625-1629.
20. Rhyu M. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 1996; 88:240-251.
21. Kohonen-Corish M, Ross VL, Doe WF, et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet 1996;59:818-824.
22. Luce MC, Binnie CG, Cayouette MC, Kam-Morgan LN. Identification of DNA mismatch repair gene mutations in hereditary nonpolyposis colon cancer. Int J Cancer 1996; 69:50-52.
23. Wijnen J, Khan PM, Vasen H, et al. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet 1996;58;300-307.
24. Piepoli A, Santoro R, Cristofaro G, et al. Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1996;110:1404-1409.
25. Aarnio M, Mecklin JP, Aaltonen LA, et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430-433.
26. Benatti P, Sassatelli R, Roncucci L, et al. Tumor spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC." A population-based study in northern Italy. Int J Cancer 1993;54:371-377.
27. Mecklin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991;68:1109-1112.
28. Watson P, Lynch HT. Extracolonic cancer in hereditary non-polyposis colorectal cancer. Cancer 1993;71:677-685.
29. Vasen HF, Offerhaus GJ, Jager FC, et al. The tumor spectrum in hereditary nonpolyposis colorectal cancer: A study of 24 kindreds in The Netherlands. Int J Cancer 1990;46:31-34.
30. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-1027.
31. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-110.